Edition:
India

China Biologic Products Holdings Inc (CBPO.OQ)

CBPO.OQ on NASDAQ Stock Exchange Global Select Market

93.54USD
16 Jul 2019
Change (% chg)

$-0.17 (-0.18%)
Prev Close
$93.71
Open
$93.72
Day's High
$94.95
Day's Low
$93.36
Volume
31,561
Avg. Vol
86,830
52-wk High
$105.01
52-wk Low
$60.09

Latest Key Developments (Source: Significant Developments)

China Biologic Products Says Unit Enters Agreement With Fujian Pingtan & Xinyu Yongshuo
Saturday, 29 Jun 2019 

June 28 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC PRODUCTS - UNIT ENTERED AGREEMENT WITH FUJIAN PINGTAN CENTURIUM INVESTMENT PARTNERSHIP & XINYU YONGSHUO MANAGEMENT AND CONSULTING.CHINA BIOLOGIC PRODUCTS - UNIT TO BUY FUJIAN PINGTAN'S 15% & XINYU YONGSHUO'S 5%, OF EQUITY INTEREST IN TIANXINFU (BEIJING) MEDICAL APPLIANCE FOR RMB820 MILLION.CHINA BIOLOGIC PRODUCTS - UPON COMPLETION OF TRANSACTION, EXPECTED TO OCCUR IN Q3 2019, TIANXINFU WILL BECOME INDIRECT WHOLLY-OWNED SUBSIDIARY OF CO.  Full Article

China Biologic Reports Q1 Adjusted Non-GAAP Earnings Per Share $1.11
Saturday, 11 May 2019 

May 10 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2019.Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.11.Q1 EARNINGS PER SHARE $0.94.Q1 EARNINGS PER SHARE ESTIMATE $1.00 -- REFINITIV IBES DATA.CHINA BIOLOGIC PRODUCTS - Q1 TOTAL SALES INCREASED BY 15.4% TO $129.8 MILLION.REITERATES ITS FORECAST FOR FULL YEAR 2019.CHINA BIOLOGIC PRODUCTS - IN MAY, BOARD AUTHORIZED NEW SHARE REPURCHASE PROGRAM UNDER WHICH CO MAY REPURCHASE UP TO $150 MILLION OF SHARES OVER NEXT 12 MONTHS.  Full Article

China Biologic Reports Financial Results For The Fourth Quarter And Fiscal Year 2018
Thursday, 7 Mar 2019 

March 6 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR 2018.Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.76.Q4 EARNINGS PER SHARE $0.87.BOARD OF DIRECTORS EXTENDS PREVIOUSLY APPROVED SHARE REPURCHASE PROGRAM.QTRLY TOTAL SALES $114.9 MILLION VERSUS $90.1 MILLION.CHINA BIOLOGIC PRODUCTS HOLDINGS - BOARD APPROVED EXTENSION TO PREVIOUSLY AUTHORIZED $100 MILLION SHARE REPURCHASE PROGRAM FOR ANOTHER 6 MONTHS UNTIL OCT 31, 2019.CHINA BIOLOGIC PRODUCTS HOLDINGS SEES 2019 NON-GAAP ADJUSTED INCOME FROM OPERATING AND NON-GAAP ADJUSTED NET INCOME TO INCREASE BY 4%-6% IN RMB TERMS OVER FY 2018 RESULTS.CHINA BIOLOGIC PRODUCTS HOLDINGS - TOTAL SALES, NON-GAAP ADJUSTED NET INCOME IN USD TERMS IN 2019 COULD BE AFFECTED BY FOREIGN CURRENCY TRANSLATION IMPACT.FY2019 EARNINGS PER SHARE VIEW $4.38, REVENUE VIEW $479.9 MILLION -- REFINITIV IBES DATA."ANTICIPATE THAT POLICY HEADWINDS WILL CONTINUE TO BE CHALLENGING IN SHORT TERM".  Full Article

China Biologic Products Holdings says On Feb 3, Board Elected Joseph Chow To Be New Chairman Of Board
Monday, 4 Feb 2019 

Feb 4 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC PRODUCTS HOLDINGS- ON FEB 1, 2019, ZHIJUN TONG INFORMED CO THAT HE WAS RESIGNING FROM HIS POSITIONS AS PRESIDENT AND DIRECTOR OF CO.CHINA BIOLOGIC PRODUCTS HOLDINGS- ON FEB 1, 2019, ZHIJUN TONG INFORMED CO THAT HE WAS RESIGNING FROM HIS POSITIONS AS PRESIDENT AND DIRECTOR OF CO .CHINA BIOLOGIC PRODUCTS HOLDINGS- ON FEB 3, BOARD UNANIMOUSLY ELECTED JOSEPH CHOW TO BE NEW CHAIRMAN OF BOARD IN SUCCESSION TO DAVID HUI LI.CHINA BIOLOGIC PRODUCTS HOLDINGS- DAVID HUI LI CONTINUES TO SERVE AS A DIRECTOR ON THE BOARD - SEC FILING.  Full Article

China Biologic Reiterates Full Year 2018 Financial Forecast
Monday, 7 Jan 2019 

Jan 7 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC REITERATES FULL YEAR 2018 FINANCIAL FORECAST.  Full Article

China Biologic Announces Dismissal Of Lawsuit Filed In Cayman Islands By Former Chairman
Friday, 14 Dec 2018 

Dec 14 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC ANNOUNCES DISMISSAL OF LAWSUIT FILED IN CAYMAN ISLANDS BY FORMER CHAIRMAN.CHINA BIOLOGIC PRODUCTS - GRAND COURT OF CAYMAN ISLANDS DISMISSED LAWSUIT PREVIOUSLY FILED AGAINST CO BY FORMER CHAIRMAN, CEO DAVID (XIAOYING) GAO.  Full Article

David Gao Confirms Lawsuit Against China Biologic Products
Wednesday, 29 Aug 2018 

Aug 29 (Reuters) - David Gao :DAVID GAO CONFIRMS LAWSUIT AGAINST CHINA BIOLOGIC PRODUCTS TO PROTECT SHAREHOLDERS’ BEST INTERESTS.DAVID GAO - CONFIRMED FILED LAWSUIT AGAINST CO RELATED TO PRIVATE PLACEMENT OF SHARES TO SELECT INVESTOR GROUP.  Full Article

China Biologic Responds To Lawsuit Filed In Cayman Islands By Former Chairman
Wednesday, 29 Aug 2018 

Aug 28 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC RESPONDS TO LAWSUIT FILED IN CAYMAN ISLANDS BY FORMER CHAIRMAN.CHINA BIOLOGIC PRODUCTS HOLDINGS - ISSUED STATEMENT IN RESPONSE TO LAWSUIT FILED AGAINST COMPANY IN CAYMAN ISLANDS BY DAVID (XIAOYING) GAO.CHINA BIOLOGIC PRODUCTS HOLDINGS INC - CLOSED 3.8 MILLION SHARES IN PRIVATE PLACEMENT & WILL CLOSE REMAINING IN ACCORDANCE WITH TRANSACTION AGREEMENTS.  Full Article

Investor Group Issues Statement Following China Biologic’s Private Placement Of Shares
Friday, 24 Aug 2018 

Aug 24 (Reuters) - Investor Group::LEADING INVESTOR GROUP ISSUES STATEMENT FOLLOWING CHINA BIOLOGIC’S DILUTIVE PRIVATE PLACEMENT OF SHARES.INVESTOR GROUP SAYS IN RELATION TO CHINA BIOLOGIC'S REJECTION OF ITS PROPOSAL, "WILL EVALUATE ALL OPTIONS, INCLUDING LEGAL ACTION".  Full Article

PW Medtech Group To Purchase 800,000 China Biologic Products Shares For $80.72 Mln
Friday, 24 Aug 2018 

Aug 24 (Reuters) - PW Medtech Group Ltd <1358.HK>::CO TO PURCHASE 800,000 CHINA BIOLOGIC PRODUCTS (CBPO) SHARES, AT A PRICE OF US$100.9 PER CBPO SHARE.AGGREGATE PURCHASE PRICE FOR CBPO SHARES SHALL BE $80.72 MILLION.  Full Article